HB 1214 Summary

• Restricts administration of abortion-inducing drugs to licensed physicians who follow FDA-approved drug label protocols and meet specific requirements including in-person examination and documentation of gestational age and intrauterine location.

• Requires physicians to provide patients with a copy of the drug label, physician contact information for a contracted backup physician, and enter into a contract with another licensed physician with hospital admitting privileges to handle complications.

• Mandates physicians schedule a follow-up appointment approximately 14 days after drug administration to confirm pregnancy termination via ultrasound imaging and assess bleeding, with documentation of efforts to ensure patient compliance.

• Requires physicians to report any adverse events (including death, hospitalization, disability, birth defects) to the FDA's MedWatch system and Indiana's medical licensing board within three days, with adverse event reports maintained as public records without patient identifying information.

• Establishes violation of these requirements as a Class A misdemeanor, with pregnant women exempt from penalty, and allows for additional disciplinary sanctions and civil liability for wrongful death and medical malpractice; effective July 1, 2012.